The British Menopause Society estimates that menopausal symptoms affect up to 80% of women, but HRT is not a universal fix. UK guidance is clear that the fit depends on the symptom pattern in front of you, the stage of the menopause transition, age, medical history and whether you still have periods or have had a hysterectomy. For many women, the right question is not whether to take HRT, but which symptoms it is likely to help and which ones need a different plan.
Why the “HRT fixes everything” idea misses the point
Menopause and perimenopause do not look the same for everyone. Symptoms can have a big impact on daily life, relationships, social life, family life and work, but some people have very few symptoms at all. Those symptoms can start in perimenopause, continue through menopause and carry on after menopause has ended.
The British Menopause Society published its statement on the updated NICE menopause guideline on 7 November 2024. The Menopause Charity’s page on the 2024 NICE guideline was last updated in November 2024 and is already set for another review in November 2027.
Where HRT tends to help most
HRT works best when the symptom is driven by low oestrogen. In practical terms, that usually means flushes, night sweats and the sleep disruption that follows them. When those symptoms ease, people often feel the biggest day-to-day change because broken sleep affects concentration, patience, energy and work performance.
Not every HRT form is meant to do the same job. Oestrogen can be taken as tablets or used as patches, spray or gel, and it can also be used as a cream or pessary for vaginal dryness. Local vaginal treatment targets one symptom directly, while tablets, patches, sprays and gels are used more broadly across the body.
Where HRT may not be enough on its own
HRT can improve some symptoms and leave others largely unchanged. Stress, anxiety, brain fog, weight change, low mood and joint pain can be more complex than a simple hormone deficiency, so starting HRT does not guarantee they will disappear. If hot flushes improve but your mood, memory or aches do not, that does not mean the treatment has failed. It may mean more than one problem is going on at once.
Menopause symptoms often overlap with work strain, poor sleep, thyroid disease, depression, musculoskeletal problems or other midlife changes, so the answer is not always to increase the HRT dose. A better match may be HRT for vasomotor symptoms plus separate treatment or support for the symptoms that sit outside hormone change.
How the NHS says to choose the right type
The type of HRT offered depends on whether you still have periods or have had a hysterectomy. That is the first branch point because treatment is not chosen from a shelf marked “menopause” and handed to everyone the same way. The route matters too, since tablets, patches, sprays and gels are all used differently, and vaginal creams or pessaries are reserved for dryness and related local symptoms.
Age, menopause symptoms and other risk factors also shape the decision. Under NHS guidance, the benefits of HRT usually outweigh the risks, and recent evidence shows the risks of serious side effects are very low. That does not mean risk is identical for every woman. The balance has to be judged individually against the person’s own health history.
What to weigh with your clinician
Under NICE guidance, people have the right to be involved in discussions and make informed decisions about their care. In practice, that means a GP or menopause specialist should be helping you weigh benefits, risks and alternatives against your own medical background, not pushing a single answer. If your symptoms are affecting work, relationships or family life, that is a clear reason to get the conversation started.
The British Menopause Society continues to issue guidance on HRT in women with breast cancer and in women with cardiovascular disease.
Why the guidance keeps evolving
The updated NICE menopause guideline and the British Menopause Society’s response to it in November 2024 show that UK practice is still being sharpened. The right plan may still include HRT, but it may also include a different route, a lower dose, vaginal treatment, or a separate approach for symptoms HRT does not touch well.